These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 20379365)

  • 1. Viral vaccines and CTL response.
    Woolard SN; Kumaraguru U
    J Biomed Biotechnol; 2010; 2010():141657. PubMed ID: 20379365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel exosome-targeted T-cell-based vaccine counteracts T-cell anergy and converts CTL exhaustion in chronic infection via CD40L signaling through the mTORC1 pathway.
    Wang R; Xu A; Zhang X; Wu J; Freywald A; Xu J; Xiang J
    Cell Mol Immunol; 2017 Jun; 14(6):529-545. PubMed ID: 27264687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multivalent minigene vaccine, containing B-cell, cytotoxic T-lymphocyte, and Th epitopes from several microbes, induces appropriate responses in vivo and confers protection against more than one pathogen.
    An LL; Whitton JL
    J Virol; 1997 Mar; 71(3):2292-302. PubMed ID: 9032365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dominant recognition by human CD8+ cytotoxic T lymphocytes of dengue virus nonstructural proteins NS3 and NS1.2a.
    Mathew A; Kurane I; Rothman AL; Zeng LL; Brinton MA; Ennis FA
    J Clin Invest; 1996 Oct; 98(7):1684-91. PubMed ID: 8833919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination of rhesus monkeys with synthetic peptide in a fusogenic proteoliposome elicits simian immunodeficiency virus-specific CD8+ cytotoxic T lymphocytes.
    Miller MD; Gould-Fogerite S; Shen L; Woods RM; Koenig S; Mannino RJ; Letvin NL
    J Exp Med; 1992 Dec; 176(6):1739-44. PubMed ID: 1460429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viral load and clinical disease enhancement associated with a lentivirus cytotoxic T lymphocyte vaccine regimen.
    Mealey RH; Leib SR; Littke MH; Wagner B; Horohov DW; McGuire TC
    Vaccine; 2009 Apr; 27(18):2453-68. PubMed ID: 19368787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanisms and biological significance of CTL avidity.
    Snyder JT; Alexander-Miller MA; Berzofskyl JA; Belyakov IM
    Curr HIV Res; 2003 Jul; 1(3):287-94. PubMed ID: 15046253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct priming and cross-priming contribute differentially to the induction of CD8+ CTL following exposure to vaccinia virus via different routes.
    Shen X; Wong SB; Buck CB; Zhang J; Siliciano RF
    J Immunol; 2002 Oct; 169(8):4222-9. PubMed ID: 12370352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TCR-independent killing of B cell malignancies by anti-third-party CTLs: the critical role of MHC-CD8 engagement.
    Lask A; Goichberg P; Cohen A; Goren-Arbel R; Milstein O; Aviner S; Feine I; Ophir E; Reich-Zeliger S; Hagin D; Klein T; Nagler A; Berrebi A; Reisner Y
    J Immunol; 2011 Aug; 187(4):2006-14. PubMed ID: 21753148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral cytotoxic T-cell memory by vaccination with recombinant Listeria monocytogenes.
    Slifka MK; Shen H; Matloubian M; Jensen ER; Miller JF; Ahmed R
    J Virol; 1996 May; 70(5):2902-10. PubMed ID: 8627765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors.
    Ossendorp F; Mengedé E; Camps M; Filius R; Melief CJ
    J Exp Med; 1998 Mar; 187(5):693-702. PubMed ID: 9480979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of pre-existing cytotoxic T lymphocytes on therapeutic vaccines.
    Sherritt MA; Gardner J; Elliott SL; Schmidt C; Purdie D; Deliyannis G; Heath WR; Suhrbier A
    Eur J Immunol; 2000 Feb; 30(2):671-7. PubMed ID: 10671225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brucella abortus conjugated with a peptide derived from the V3 loop of human immunodeficiency virus (HIV) type 1 induces HIV-specific cytotoxic T-cell responses in normal and in CD4+ cell-depleted BALB/c mice.
    Lapham C; Golding B; Inman J; Blackburn R; Manischewitz J; Highet P; Golding H
    J Virol; 1996 May; 70(5):3084-92. PubMed ID: 8627787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of vigorous cytotoxic T-lymphocyte responses by live attenuated simian immunodeficiency virus.
    Johnson RP; Glickman RL; Yang JQ; Kaur A; Dion JT; Mulligan MJ; Desrosiers RC
    J Virol; 1997 Oct; 71(10):7711-8. PubMed ID: 9311855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic T lymphocytes in protection against equine infectious anemia virus.
    McGuire TC; Fraser DG; Mealey RH
    Anim Health Res Rev; 2004 Dec; 5(2):271-6. PubMed ID: 15984338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics and viral protein specificity of the cytotoxic T lymphocyte response in healthy adults immunized with live attenuated varicella vaccine.
    Sharp M; Terada K; Wilson A; Nader S; Kinchington PE; Ruyechan WT; Hay J; Arvin AM
    J Infect Dis; 1992 May; 165(5):852-8. PubMed ID: 1314871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical components of a DNA fusion vaccine able to induce protective cytotoxic T cells against a single epitope of a tumor antigen.
    Rice J; Buchan S; Stevenson FK
    J Immunol; 2002 Oct; 169(7):3908-13. PubMed ID: 12244189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Role of Influenza Virus Exposure History in Determining Pandemic Susceptibility and CD8+ T Cell Responses.
    Quiñones-Parra SM; Clemens EB; Wang Z; Croom HA; Kedzierski L; McVernon J; Vijaykrishna D; Kedzierska K
    J Virol; 2016 Aug; 90(15):6936-6947. PubMed ID: 27226365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1 vaccination administered intramuscularly can induce both systemic and mucosal T cell immunity in HIV-1-uninfected individuals.
    Musey L; Ding Y; Elizaga M; Ha R; Celum C; McElrath MJ
    J Immunol; 2003 Jul; 171(2):1094-101. PubMed ID: 12847284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of protective cytotoxic T-cell responses by a B-cell-based cellular vaccine requires stable expression of antigen.
    Guo S; Xu J; Denning W; Hel Z
    Gene Ther; 2009 Nov; 16(11):1300-13. PubMed ID: 19641529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.